Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
Clinical trial NCT04239391 · UNKNOWN
Trial details
- NCT number
- NCT04239391
- Sponsor
- Rockwell Medical Technologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-08-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.